Long-term anticholinergic add-on therapy in overactive bladder (OAB) patients refractory to mirabegron monotherapy: a multicentre, randomized study (MILAI II study)

Yamaguchi O1, Kakizaki H2, Homma Y3, Igawa Y4, Takeda M5, Nishizawa O6, Gotoh M7, Yoshida M8, Yokoyama O9, Seki N10, Hamada T11, Kuroishi K11

Research Type

Clinical

Abstract Category

Overactive Bladder

Abstract 9
Lower Urinary Tract and Therapeutics
Scientific Podium Short Oral Session 2
Wednesday 13th September 2017
09:15 - 09:22
Cavaniglia B
Overactive Bladder Incontinence Urgency/Frequency
1. Division of Bioengineering and LUTD Research, Nihon University, School of Engineering, Koriyama, Japan, 2. Department of Urology, Asahikawa Medical University, Asahikawa, Japan, 3. Department of Urology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, 4. Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, Tokyo, Japan, 5. Department of Urology, Division of Clinical Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Chuo, Japan, 6. Department of Urology, North Alps Medical Center Azumi Hospital, Kitaazumi, Japan, 7. Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 8. Department of Urology, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan, 9. Department of Urology, University of Fukui Faculty of Medical Sciences, Fukui, Japan, 10. Department of Urology, Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan, 11. Astellas Pharma Inc, Tokyo, Japan
Presenter
O

Osamu Yamaguchi

Links

Abstract